Surmodics reported $0 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.





Eps Change Date
Abbott USD 1.15 0.35 Mar/2026
Align Technology USD 2.58 0.71 Mar/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
Artivion USD -0.02 0.2 Dec/2025
Baxter International USD 0.36 0.08 Mar/2026
Boston Scientific USD 0.8 0 Mar/2026
EDAP TMS EUR -0.13 0.02 Sep/2025
Edwards Lifesciences USD 0.78 0.2 Mar/2026
Haemonetics USD 1.31 0.04 Dec/2025
Heron Therapeutics USD -0.02 0.02 Dec/2025
J&J USD 2.7 0.24 Mar/2026
Merit Medical Systems USD 0.86 0.18 Mar/2026
Mesa Laboratories USD -0.31 0.94 Dec/2024
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Option Care Health USD 0.4 0.06 Mar/2026
Stryker USD 2.6 1.87 Mar/2026
Surmodics USD 0 0.25 Jun/2025
Trinity Biotech USD -0.28 0.96 Sep/2025